Exagen Inc.
XGN
$4.36
$0.051.16%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 4.06% | -3.55% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.06% | -3.55% | |||
| Cost of Revenue | -4.36% | 3.57% | |||
| Gross Profit | 10.85% | -8.63% | |||
| SG&A Expenses | -2.88% | 8.55% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.10% | 6.20% | |||
| Operating Income | 31.38% | -60.48% | |||
| Income Before Tax | 15.64% | 34.24% | |||
| Income Tax Expenses | 176.92% | 1,200.00% | |||
| Earnings from Continuing Operations | 15.11% | 34.06% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 15.11% | 34.06% | |||
| EBIT | 31.38% | -60.48% | |||
| EBITDA | 35.66% | -75.84% | |||
| EPS Basic | 16.09% | 35.84% | |||
| Normalized Basic EPS | 24.04% | -37.99% | |||
| EPS Diluted | 16.09% | 35.84% | |||
| Normalized Diluted EPS | 24.04% | -37.99% | |||
| Average Basic Shares Outstanding | 1.18% | 2.77% | |||
| Average Diluted Shares Outstanding | 1.18% | 2.77% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||